Insufficient scRNA-seq data for expression of RIOX1 at single-cell level.
Insufficient scRNA-seq data for expression of RIOX1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 328.84 | 180 / 180 | 100% | 13.61 | 430 / 430 |
skin | 100% | 501.64 | 1808 / 1809 | 100% | 29.54 | 471 / 472 |
pancreas | 100% | 369.91 | 327 / 328 | 100% | 14.03 | 178 / 178 |
breast | 100% | 411.97 | 458 / 459 | 100% | 22.51 | 1117 / 1118 |
intestine | 100% | 477.19 | 966 / 966 | 100% | 18.06 | 525 / 527 |
thymus | 100% | 384.73 | 652 / 653 | 100% | 16.37 | 602 / 605 |
uterus | 100% | 477.95 | 170 / 170 | 99% | 18.78 | 455 / 459 |
esophagus | 100% | 497.78 | 1440 / 1445 | 99% | 16.52 | 182 / 183 |
stomach | 99% | 404.99 | 357 / 359 | 100% | 16.66 | 285 / 286 |
liver | 100% | 368.21 | 226 / 226 | 99% | 9.90 | 402 / 406 |
kidney | 100% | 345.87 | 89 / 89 | 99% | 11.16 | 890 / 901 |
bladder | 100% | 469.71 | 21 / 21 | 98% | 16.33 | 493 / 504 |
prostate | 100% | 366.31 | 245 / 245 | 97% | 11.99 | 488 / 502 |
lung | 95% | 317.37 | 547 / 578 | 100% | 16.92 | 1153 / 1155 |
adrenal gland | 99% | 430.42 | 256 / 258 | 94% | 9.98 | 216 / 230 |
brain | 99% | 355.45 | 2604 / 2642 | 82% | 6.18 | 580 / 705 |
eye | 0% | 0 | 0 / 0 | 100% | 20.10 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.30 | 29 / 29 |
spleen | 100% | 567.77 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.15 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.48 | 1 / 1 |
adipose | 100% | 360.58 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 344.21 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 213.44 | 789 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 333.21 | 823 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 86% | 458.36 | 799 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006338 | Biological process | chromatin remodeling |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0036139 | Molecular function | peptidyl-histidine dioxygenase activity |
GO_0140457 | Molecular function | protein demethylase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0032453 | Molecular function | histone H3K4 demethylase activity |
GO_0140680 | Molecular function | histone H3K36me/H3K36me2 demethylase activity |
GO_0034647 | Molecular function | histone H3K4me/H3K4me2/H3K4me3 demethylase activity |
GO_0051864 | Molecular function | histone H3K36 demethylase activity |
GO_0016706 | Molecular function | 2-oxoglutarate-dependent dioxygenase activity |
Gene name | RIOX1 |
Protein name | Ribosomal oxygenase 1 (60S ribosomal protein L8 histidine hydroxylase) (Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66) (EC 1.14.11.27, EC 1.14.11.79) (Myc-associated protein with JmjC domain) (Nucleolar protein 66) (hsNO66) (Ribosomal oxygenase NO66) (ROX) |
Synonyms | NO66 C14orf169 MAPJD |
Description | FUNCTION: Oxygenase that can act as both a histone lysine demethylase and a ribosomal histidine hydroxylase . Specifically demethylates 'Lys-4' (H3K4me) and 'Lys-36' (H3K36me) of histone H3, thereby playing a central role in histone code (By similarity). Preferentially demethylates trimethylated H3 'Lys-4' (H3K4me3) and monomethylated H3 'Lys-4' (H3K4me1) residues, while it has weaker activity for dimethylated H3 'Lys-36' (H3K36me2) (By similarity). Acts as a regulator of osteoblast differentiation via its interaction with SP7/OSX by demethylating H3K4me and H3K36me, thereby inhibiting SP7/OSX-mediated promoter activation (By similarity). Also catalyzes demethylation of non-histone proteins, such as CGAS: demethylation of monomethylated CGAS promotes interaction between CGAS and PARP1, followed by PARP1 inactivation (By similarity). Also catalyzes the hydroxylation of 60S ribosomal protein L8 on 'His-216', thereby playing a role in ribosome biogenesis . Participates in MYC-induced transcriptional activation . . |
Accessions | Q9H6W3 ENST00000304061.8 [Q9H6W3-1] |